Literature DB >> 215713

Prevalence of antibody to the Norwalk agent by a newly developed immune adherence hemagglutination assay.

A Z Kapikian, H B Greenberg, W L Cline, A R Kalica, R G Wyatt, H D James, N L Lloyd, R M Chanock, R W Ryder, H W Kim.   

Abstract

An immune adherence hemagglutination assay (IAHA) for the detection of antibody to the Norwalk agent of acute epidemic nonbacterial gastroenteritis was developed using as antigen virus purified from stool from an experimentally infected volunteer. The assay was sensitive and specific and was efficient for detecting Norwalk antibody seroresponses. The prevalence of Norwalk antibody in various groups in the United States was studied. Antibody to the Norwalk agent was acquired gradually, beginning slowly in childhood and accelerating in the adult period so that by the fifth decade 50% possessed antibody. This pattern of antibody acquisition contrasted sharply with that for the human rotavirus of infantile gastroenteritis. Rotavirus antibody was acquired during early childhood by almost all individuals in the pediatric groups studied. Antibody to the Norwalk agent was also found in rural Bangladesh; in a small prevalence survey of 39 children and adults 21% possessed Norwalk IAHA antibody, whereas 95% possessed antibody to the human rotavirus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 215713     DOI: 10.1002/jmv.1890020402

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  20 in total

1.  Study of Norwalk virus and Mexico virus infections at Ga-Rankuwa Hospital, Ga-Rankuwa, South Africa.

Authors:  T K Smit; A D Steele; I Peenze; X Jiang; M K Estes
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Prevalence of antibody to the Norwalk virus in various countries.

Authors:  H B Greenberg; J Valdesuso; A Z Kapikian; R M Chanock; R G Wyatt; W Szmuness; J Larrick; J Kaplan; R H Gilman; D A Sack
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

3.  Prevalence of noroviruses and sapoviruses in swine of various ages determined by reverse transcription-PCR and microwell hybridization assays.

Authors:  Qiu-Hong Wang; Menira Souza; Julie A Funk; Wei Zhang; Linda J Saif
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 4.  Porcine enteric caliciviruses: genetic and antigenic relatedness to human caliciviruses, diagnosis and epidemiology.

Authors:  Qiu-Hong Wang; Veronica Costantini; Linda J Saif
Journal:  Vaccine       Date:  2006-12-29       Impact factor: 3.641

Review 5.  Viral gastroenteritis: small round structured viruses, caliciviruses and astroviruses. Part II. The epidemiological perspective.

Authors:  E O Caul
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

6.  Antigenic characterization of human and animal rotaviruses by immune adherence hemagglutination assay (IAHA): evidence for distinctness of IAHA and neutralization antigens.

Authors:  A Z Kapikian; W L Cline; H B Greenberg; R G Wyatt; A R Kalica; C E Banks; H D James; J Flores; R M Chanock
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

Review 7.  Human viral gastroenteritis.

Authors:  G Cukor; N R Blacklow
Journal:  Microbiol Rev       Date:  1984-06

8.  Assay of human rotavirus antibody by immune adherence hemagglutination with a cultivable human rotavirus as antigen.

Authors:  S Matsuno; S Inouye; A Hasegawa; R Kono
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948

9.  Comparative study of the acquisition of antibody to Norwalk virus in pediatric populations.

Authors:  G Cukor; N R Blacklow; P Echeverria; M K Bedigian; H Puruggan; V Basaca-Sevilla
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

10.  Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations.

Authors:  K Y Green; J F Lew; X Jiang; A Z Kapikian; M K Estes
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.